News

Fintel on MSN7d
William Blair Initiates Coverage of Ocular Therapeutix (OCUL) with Outperform Recommendation
Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a ...
William Blair Sticks to Their Buy Rating for Skye Bioscience (SKYE)
In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Skye Bioscience (SKYE – Research Report). The company’s ...
William Blair Sticks to Its Buy Rating for 908 Devices (MASS)
In a report released today, Matt Larew from William Blair maintained a Buy rating on 908 Devices (MASS – Research Report). The company’s shares ...
Fintel on MSN11d
William Blair Initiates Coverage of Savers Value Village (SVV) with Outperform Recommendation
Fintel reports that on April 4, 2025, William Blair initiated coverage of Savers Value Village (NYSE:SVV) with a Outperform ...
TipRanks on MSN8d
Kalaris Therapeutics initiated with an Outperform at William Blair
William Blair initiated coverage of Kalaris Therapeutics (KLRS) with an Outperform rating and $21 fair value estimate. Kalaris is a clinical-stage ...
Fintel on MSN13d
William Blair Downgrades nCino (NCNO)
Fintel reports that on April 2, 2025, William Blair downgraded their outlook for nCino (NasdaqGS:NCNO) from Outperform to ...
William Blair Remains a Buy on Simply Good Foods (SMPL)
In a report released today, Jon Andersen from William Blair maintained a Buy rating on Simply Good Foods (SMPL – Research Report). The ...